journal article·2025-12Open access

TSH Ligand‐Based CAR‐T Cell Effectively Eradicates TSHR‐Positive Thyroid Cancer with Favorable Safety Profile

Fei Wang, Hui Zuo, Li Liu, Shiyuan Wang, Haifang Zhao, Zhao Liu, Gang Wang, Zhao Liu, Junnian Zheng, Chuan Xu, Hongwei Du

Advanced Science· Volume 12· Issue 46

Abstract

Abstract CAR‐T therapy faces significant challenges in solid tumors, including the shortage of targetable antigen and the immunogenicity of CAR molecules. Here, TSHR is identified as specifically expressed in DTC, but absent in other normal tissues, making it an ideal target for CAR‐T therapy. To overcome CAR immunogenicity, a novel CAR molecule is engineered using TSH (TSH‐CAR), the natural ligand of TSHR, as the antigen‐binding domain to target TSHR. The TSH‐CAR‐T cells demonstrate effective antitumor activity against TSHR‐positive differentiated thyroid cancer (DTC) cell lines in vitro, accompanied by cytokine release (IFNγ, IL‐2) and robust proliferation. In addition, TSH‐CAR‐T cells achieved complete tumor eradication and sustained remission in two distinct thyroid cancer xenograft models. Furthermore, for comprehensively evaluate the safety profile of TSH‐CAR‐T cell, a murine TSH‐CAR (mTSH‐CAR‐T) is engineered, revealing that mTSH‐CAR‐T cells effectively control mTSHR‐positive tumor growth without evident on‐target/off‐tumor effect in immunocompetent syngeneic mouse tumor models, except for the transient and reversible impairment of thyroid follicles, which is acceptable given prior thyroidectomy in DTC patients. The potent preclinical efficacy and favorable safety profile strongly support the clinical translation of TSH‐CAR‐T for patients suffering from metastatic and radioiodine‐resistant DTC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: CAR-T cell therapy research · Biomedical and Engineering Education · Nanowire Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cancer Institute Xuzhou Medical University 209 Tongshan Road Xuzhou Jiangsu 221004 China

Center of Clinical Oncology the Affiliated Hospital of Xuzhou Medical University 99 Huaihai Road Xuzhou Jiangsu 221002 China

Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy Xuzhou Medical University 209 Tongshan Road Xuzhou Jiangsu 221004 China

Department of General Surgery the Affiliated Hospital of Xuzhou Medical University 99 Huaihai Road Xuzhou 221002 China

Department of Nuclear Medicine The Affiliated Hospital of Xuzhou Medical University 99 West Huaihai Road Xuzhou Jiangsu 221002 China

Department of Oncology & Cancer Institute Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu 610072 China

Jinfeng Laboratory Chongqing 401329 China

Funding

National Natural Science Foundation of China · Chongqing Research Program of Technological Innovation and Application Demonstration · National Key Research and Development Program of China

References (60)

Show source-provided references
1. 10.1016/S2213-8587(21)00027-910.1016/S2213-8587(21)00027-9 ↗
2. 10.1016/j.ecl.2018.10.00210.1016/j.ecl.2018.10.002 ↗
3. 10.3322/caac.2170810.3322/caac.21708 ↗
4. 10.3389/fendo.2020.0010210.3389/fendo.2020.00102 ↗
5. 10.1089/thy.2015.010410.1089/thy.2015.0104 ↗
6. 10.1007/s12094-016-1554-510.1007/s12094-016-1554-5 ↗
7. 10.1590/2359-399700000024510.1590/2359-3997000000245 ↗
8. 10.3389/fendo.2020.0008210.3389/fendo.2020.00082 ↗
9. 10.1530/ERC-17-054210.1530/ERC-17-0542 ↗
10. 10.3322/caac.2183410.3322/caac.21834 ↗
11. 10.1016/S1470-2045(19)30823-X10.1016/S1470-2045(19)30823-X ↗
12. 10.1016/j.tmrv.2019.08.00310.1016/j.tmrv.2019.08.003 ↗
13. 10.3389/fimmu.2023.118804910.3389/fimmu.2023.1188049 ↗
14. 10.1016/S2352-3026(22)00291-510.1016/S2352-3026(22)00291-5 ↗
15. 10.15252/emmm.20160748510.15252/emmm.201607485 ↗
16. 10.3390/cancers1411266710.3390/cancers14112667 ↗
17. 10.1038/mt.2010.2410.1038/mt.2010.24 ↗
18. 10.1016/j.ymthe.2023.06.00610.1016/j.ymthe.2023.06.006 ↗
19. 10.1016/j.jcyt.2020.04.08810.1016/j.jcyt.2020.04.088 ↗
20. 10.3389/fimmu.2021.70100610.3389/fimmu.2021.701006 ↗
21. 10.1186/s12943-023-01723-z10.1186/s12943-023-01723-z ↗
22. 10.1038/s41408-021-00459-710.1038/s41408-021-00459-7 ↗
23. 10.1186/s12967-023-04292-310.1186/s12967-023-04292-3 ↗
24. 10.3390/cells907173010.3390/cells9071730 ↗
25. 10.1152/physrev.00031.200110.1152/physrev.00031.2001 ↗
26. 10.3389/fphar.2023.129185610.3389/fphar.2023.1291856 ↗
27. 10.1210/jcem-57-1-14010.1210/jcem-57-1-140 ↗
28. 10.1177/03008916110970042010.1177/030089161109700420 ↗
29. 10.1245/s10434-011-2047-y10.1245/s10434-011-2047-y ↗
30. 10.1016/j.surg.2023.05.04510.1016/j.surg.2023.05.045 ↗
31. 10.1530/ERC-17-001010.1530/ERC-17-0010 ↗
32. 10.1210/clinem/dgab81910.1210/clinem/dgab819 ↗
33. 10.1016/S0140-6736(23)00020-X10.1016/S0140-6736(23)00020-X ↗
34. 10.1002/mog2.7000810.1002/mog2.70008 ↗
35. 10.1038/s41571-021-00476-210.1038/s41571-021-00476-2 ↗
36. 10.1016/j.ygcen.2024.11458010.1016/j.ygcen.2024.114580 ↗
37. 10.1152/physrev.00031.200110.1152/physrev.00031.2001 ↗
38. 10.1158/0008-5472.CAN-06-402610.1158/0008-5472.CAN-06-4026 ↗
39. 10.1016/j.nucmedbio.2011.03.00110.1016/j.nucmedbio.2011.03.001 ↗
40. 10.1186/s13044-024-00199-310.1186/s13044-024-00199-3 ↗
41. 10.1002/cac2.1260510.1002/cac2.12605 ↗
42. 10.1182/blood-2010-07-29452010.1182/blood-2010-07-294520 ↗
43. 10.3390/antib801002110.3390/antib8010021 ↗
44. 10.1038/s41571-019-0297-y10.1038/s41571-019-0297-y ↗
45. 10.1016/j.ccell.2019.12.01410.1016/j.ccell.2019.12.014 ↗
46. 10.1126/scisignal.aat675310.1126/scisignal.aat6753 ↗
47. 10.1089/thy.1997.7.87910.1089/thy.1997.7.879 ↗
48. 10.1210/endo.142.3.801210.1210/endo.142.3.8012 ↗
49. 10.1016/j.mce.2017.02.01510.1016/j.mce.2017.02.015 ↗
50. 10.1038/mt.2013.1710.1038/mt.2013.17 ↗
51. 10.1042/BST2016003710.1042/BST20160037 ↗
52. 10.1530/JME-13-016010.1530/JME-13-0160 ↗
53. 10.1158/2159-8290.CD-17-053810.1158/2159-8290.CD-17-0538 ↗
54. 10.1158/2767-9764.CRC-24-028610.1158/2767-9764.CRC-24-0286 ↗
55. 10.1016/j.ccell.2020.11.00510.1016/j.ccell.2020.11.005 ↗
56. 10.1097/CJI.000000000000030110.1097/CJI.0000000000000301 ↗
57. 10.1016/S1470-2045(21)00332-610.1016/S1470-2045(21)00332-6 ↗
58. 10.1089/thy.2023.046310.1089/thy.2023.0463 ↗
59. 10.1016/j.ccell.2019.01.00210.1016/j.ccell.2019.01.002 ↗
60. 10.1038/s43018-021-00244-210.1038/s43018-021-00244-2 ↗